91 related articles for article (PubMed ID: 3765523)
1. [3-HAA-antigen and immunoreactivity indices in patients with bladder tumors].
Korosteleva TA; Rabkova LM; Belokhvostova AT; Movsesian KS; Skadova VM
Vopr Onkol; 1986; 32(9):48-53. PubMed ID: 3765523
[TBL] [Abstract][Full Text] [Related]
2. [Effect of 3-hydroxyanthranilic acid-antigen on the migration of peripheral blood leukocytes in patients with bladder tumors].
Korosteleva TA; Kliucharev BV; Skadova VM; Vorob'ev AV; Chebotkevich VN
Vopr Onkol; 1987; 33(5):59-62. PubMed ID: 3296440
[TBL] [Abstract][Full Text] [Related]
3. [Immunoreactivity and the effect on it of the 3-HAA antigen in patients with gastrointestinal tumors].
Korosteleva TA; Mel'nikov RA; Belokhvostova AT; Movsesian KS; Skadova VM
Vopr Onkol; 1986; 32(8):38-45. PubMed ID: 3765508
[TBL] [Abstract][Full Text] [Related]
4. [Effect of an operation on the immunoreactivity indices, their postoperative dynamics and the effect of 3-HAA-antigen on these indices in patients with gastrointestinal tumors].
Korosteleva TA; Pavlov KA; Mel'nikov RA; Saprin AN; Belokhvostova AT
Vopr Onkol; 1985; 31(6):52-60. PubMed ID: 4024547
[TBL] [Abstract][Full Text] [Related]
5. [3-hydroxyanthranilic acid content in the urine of bladder cancer patients].
Korosteleva TA; Kliucharev BV; Benteleva TA
Vopr Onkol; 1979; 25(6):36-9. PubMed ID: 462869
[TBL] [Abstract][Full Text] [Related]
6. [Detection of an antigen containing 3-hydroxyanthranilic acid in the sera of patients with tumors of different localizations].
Korosteleva TA; Kliucharev BV; Mel'nikov RA; Belokhvostova AT
Biull Eksp Biol Med; 1976 Jul; 82(7):850-2. PubMed ID: 953351
[TBL] [Abstract][Full Text] [Related]
7. [Determination of leukocyte sensitization to tumor and embryonic tissue antigens in cancer of the large intestine].
Novikov DK; Shmakov AP
Vopr Onkol; 1981; 27(8):40-5. PubMed ID: 6269300
[TBL] [Abstract][Full Text] [Related]
8. [Immunologic determination of 3-hydroxyanthranilic acid in the blood of patients with tumors of the large intestine and rectum].
Korosteleva TA; Mel'nikov RA; Belokhvostova AT
Vopr Onkol; 1976; 22(5):28-32. PubMed ID: 936541
[TBL] [Abstract][Full Text] [Related]
9. [Suppression of leukocyte migration in bladder cancer with tumor antigens before and after surgery].
Borisenko ID; Novikov DK; Shein IA
Urol Nefrol (Mosk); 1978; (2):26-9. PubMed ID: 644715
[No Abstract] [Full Text] [Related]
10. [An immunologic method of detecting 3-hydroxyanthranilic acid in the serum of patients with urinary bladder cancer].
Korosteleva TA; Kliucharev BV; Belokhvostova AT
Vopr Onkol; 1971; 17(3):59-63. PubMed ID: 4998157
[No Abstract] [Full Text] [Related]
11. [In vitro migration inhibition of leukocytes from cancer patients by extracts of autologous and homologous tumors].
Novikov DK; Adamenko GP
Dokl Akad Nauk SSSR; 1974; 217(3):715-8. PubMed ID: 4848926
[No Abstract] [Full Text] [Related]
12. [Effect of serum fractions from cancer patients on leukocyte migration out of capillary tubes].
Novikov DK; Shmakov AP; Borisenko ID
Biull Eksp Biol Med; 1978 Nov; 86(11):568-72. PubMed ID: 363203
[TBL] [Abstract][Full Text] [Related]
13. [Suppression of the formation of cells secreting antibodies and antigen-dependent nonspecific immunoglobulins in mice receiving isologous antierythrocyte immunoglobulins].
Agadzhanian MG; Nesterenko VG; Megrabian TB; Rubakova EI; Sidorova EV
Biull Eksp Biol Med; 1985 Mar; 99(3):328-30. PubMed ID: 4039200
[TBL] [Abstract][Full Text] [Related]
14. [Immunosuppressive activity of the blood serum of patients with cancer of the corpus uteri].
Movsesian MA; Adamian RT; Pogosian NV
Eksp Onkol; 1989; 11(2):73-4. PubMed ID: 2737136
[TBL] [Abstract][Full Text] [Related]
15. The excretion of 3-hydroxyanthranilic acid in patients with bladder and kidney carcinoma.
Teulings FA; Mulder-Kooy GE; Peters HA; Fokkens W; Van Der Werf-Messing B
Acta Vitaminol Enzymol; 1975; 29(1-6):108-12. PubMed ID: 1244078
[TBL] [Abstract][Full Text] [Related]
16. [Antigen, containing tryptophan metabolite, 3-oxyanthranilic acid, in blood serum of patients with stomach neoplasms].
Korosteleva TA; Mel'nikov RA; Belokhvostova AT
Vopr Onkol; 1976; 22(10):22-6. PubMed ID: 1014489
[TBL] [Abstract][Full Text] [Related]
17. [3-Hydroxyanthranilic acid in the blood of patients with kidney tumors].
Korosteleva TA; Kliucharev BV; Belokhvostova AT
Vopr Onkol; 1976; 22(11):95-8. PubMed ID: 1014510
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic significance of determining 3-hydroxyanthranilic acid in patients with precancerous diseases and cancer of the bladder].
Klimenko IA; Romanenko AM; Korosteleva TA; Belokhvostova AT
Urol Nefrol (Mosk); 1986; (6):30-4. PubMed ID: 3811070
[No Abstract] [Full Text] [Related]
20. [Immunological reactivity study of patients with uterine trophoblastic tumors].
Grigorova TM; Stas TA; Kadagidze ZG; Kovaleva VL
Vopr Onkol; 1979; 25(7):86-90. PubMed ID: 225875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
